Zhuhai Digifluidic Biotechnology Co. announced that it will raise CNY 49,504,500 in equity round of funding on September 9, 2022. The transaction will include participation from new investors, Wuhan Easy Diagnosis Biomedicine Co.,Ltd. for CNY 10,000,000 for 4.0032% stake, Ganjiang New District Boqu Investment Management Partnership Enterprise, a fund managed by Guangzhou Funway Asset Management Co., Ltd., an investment arm for CNY 20,000,000 and 8.0064% stake, Guangzhou Huiju Xinxing Equity Investment Partnership for CNY 19,500,000 for 7.8062% stake and individual investor, Shi Wei for CNY 4,500 and 0.1201%.

Upon closing the registered capital of the company will increase from CNY 3,000,000 to CNY 3,747,000.